Gedeon Richter

• Founded

  1 Jan 1901

Sources: ror.org

• NCT06823856

  Phase 1, Completed, 64 people, 12 Feb 2025

• NCT06792968

  Phase 1, Completed, 64 people, 27 Jan 2025

• NCT06766500

  Phase 1, Completed, 64 people, 9 Jan 2025

• NCT04524026

  Collaborator, Phase 2, Completed, 25 people, 24 Aug 2020

• NCT02223416

  Phase 1, Completed, 22 Aug 2014

• NCT02001584

  Phase 1, Completed, 5 Dec 2013

• NCT00524615

  Collaborator, Phase 4, Status unknown, 160 people, 3 Sept 2007

• Glucose excursions throughout the reproductive life stages in women with diabetes

  15 Sept 2026

Sources: api.crossref.org

• Contemporary menopausal hormone therapy and thrombotic disease: nationwide nested case-control study

  Fees or honoraria, 23 Sept 2026

• Menopause Hormone Therapy in Women With Cardiovascular Risk Factors or Established Ischemic Heart Disease: A Joint FIGO and WHF Position Paper

  Consulting or advice, 22 Sept 2026

• Estradiol transdermal spray for menopausal symptom management: From RCT to real-world evidence

  Fees or honoraria, 17 Sept 2026

• From PCOS to PMOS: An EMAS clinical guide to the proposed terminology and its relevance to menopause care

  Consulting or advice, Fees or honoraria, Board or leadership role, 9 Sept 2026

• Incidence of systemic physical multimorbidity among people with schizophrenia-spectrum or bipolar-spectrum disorders compared with age-matched and sex-matched individuals in Queensland, Australia: a statewide, hospital cohort study

  Fees or honoraria, 1 Sept 2026

• A clinical decision support tool for accurate hip fracture prediction: A nationwide cohort study

  Consulting or advice, Fees or honoraria, 27 Aug 2026

• Effectiveness of a digital cognitive behavioral therapy application for vasomotor symptoms in menopausal women: An open-label pilot randomized controlled trial

  Fees or honoraria, 21 Aug 2026

• Hormone therapy (HT) in women with premature ovarian insufficiency or early menopause: Time to think of a new paradigm for healthy aging. A joint FIGO and IMS position paper

  Consulting or advice, 18 Aug 2026

• Female Adipose Tissue Sex Steroid Biosynthesis

  Fees or honoraria, 3 Oct 2025

• Brain age gap reduction following exercise mirrors clinical improvements in schizophrenia spectrum disorders

  Consulting or advice, Fees or honoraria, 19 Sept 2025

• Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial

  Fees or honoraria, 11 Jan 2022

• Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial

  Fees or honoraria, 13 Apr 2021

Sources: pubmed.ncbi.nlm.nih.gov

• SCIP—A Novel and Efficient Screening Tool for Detecting Cognitive Impairment among Older Adults with Type 2 Diabetes

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025